A review on anti‐tuberculosis peptides: Impact of peptide structure on anti‐tuberculosis activity

Sutharsana Yathursan,Siouxsie Wiles,Hannah Read,Vijayalekshmi Sarojini
DOI: https://doi.org/10.1002/psc.3213
2019-09-12
Journal of Peptide Science
Abstract:<p>Antibiotic resistance is a major public health problem globally. Particularly concerning amongst drug‐resistant human pathogens is <i>Mycobacterium tuberculosis</i> that causes the deadly infectious tuberculosis (TB) disease. Significant issues associated with current treatment options for drug‐resistant TB and the high rate of mortality from the disease makes the development of novel treatment options against this pathogen an urgent need. Antimicrobial peptides are part of innate immunity in all forms of life and could provide a potential solution against drug‐resistant TB. This review is a critical analysis of antimicrobial peptides that are reported to be active against the <i>M tuberculosis</i> complex exclusively. However, activity on non‐TB strains such as <i>Mycobacterium avium</i> and <i>Mycobacterium intracellulare</i>, whenever available, have been included at appropriate sections for these anti‐TB peptides. Natural and synthetic antimicrobial peptides of diverse sequences, along with their chemical structures, are presented, discussed, and correlated to their observed antimycobacterial activities. Critical analyses of the structure allied to the anti‐mycobacterial activity have allowed us to draw important conclusions and ideas for research and development on these promising molecules to realise their full potential. Even though the review is focussed on peptides, we have briefly summarised the structures and potency of the various small molecule drugs that are available and under development, for TB treatment.</p>
biochemistry & molecular biology,chemistry, analytical
What problem does this paper attempt to address?